Spero Therapeutics (SPRO) Other Operating Expenses (2022 - 2025)

Spero Therapeutics has reported Other Operating Expenses for 3 years, with the latest figure at $587000.0 in Q3 2025.

• For the quarter ending Q3 2025, Other Operating Expenses changed N/A year-over-year to $587000.0; the trailing twelve-month figure through Mar 2026 stood at $587000.0 (changed N/A YoY), and the FY2025 full-year result was $587000.0, changed N/A from the prior year.
• Other Operating Expenses for Q3 2025 stood at $587000.0, down from $5.3 million in the prior quarter.
• The five-year high for Other Operating Expenses was $8.6 million in Q4 2022, with the low at $587000.0 in Q3 2025.
• Historically, Other Operating Expenses has averaged $4.8 million across 3 years, with a median of $5.3 million in 2023.